These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20529487)

  • 1. Identification of depression in diabetes: the efficacy of PHQ-9 and HADS-D.
    Reddy P; Philpot B; Ford D; Dunbar JA
    Br J Gen Pract; 2010 Jun; 60(575):e239-45. PubMed ID: 20529487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two self-rating scales to detect depression: HADS and PHQ-9.
    Hansson M; Chotai J; Nordstöm A; Bodlund O
    Br J Gen Pract; 2009 Sep; 59(566):e283-8. PubMed ID: 19761655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care.
    Cameron IM; Crawford JR; Lawton K; Reid IC
    Br J Gen Pract; 2008 Jan; 58(546):32-6. PubMed ID: 18186994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential item functioning of the HADS and PHQ-9: an investigation of age, gender and educational background in a clinical UK primary care sample.
    Cameron IM; Crawford JR; Lawton K; Reid IC
    J Affect Disord; 2013 May; 147(1-3):262-8. PubMed ID: 23218250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting depression in patients with coronary heart disease: a diagnostic evaluation of the PHQ-9 and HADS-D in primary care, findings from the UPBEAT-UK study.
    Haddad M; Walters P; Phillips R; Tsakok J; Williams P; Mann A; Tylee A
    PLoS One; 2013; 8(10):e78493. PubMed ID: 24130903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran.
    Khamseh ME; Baradaran HR; Javanbakht A; Mirghorbani M; Yadollahi Z; Malek M
    BMC Psychiatry; 2011 Apr; 11():61. PubMed ID: 21496289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring depression severity in general practice: discriminatory performance of the PHQ-9, HADS-D, and BDI-II.
    Cameron IM; Cardy A; Crawford JR; du Toit SW; Hay S; Lawton K; Mitchell K; Sharma S; Shivaprasad S; Winning S; Reid IC
    Br J Gen Pract; 2011 Jul; 61(588):e419-26. PubMed ID: 21722450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis.
    Hitchon CA; Zhang L; Peschken CA; Lix LM; Graff LA; Fisk JD; Patten SB; Bolton J; Sareen J; El-Gabalawy R; Marriott J; Bernstein CN; Marrie RA
    Arthritis Care Res (Hoboken); 2020 Aug; 72(8):1130-1139. PubMed ID: 31199570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reliability and validity of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with infertility.
    Maroufizadeh S; Omani-Samani R; Almasi-Hashiani A; Amini P; Sepidarkish M
    Reprod Health; 2019 Sep; 16(1):137. PubMed ID: 31500644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for depression in acute coronary syndrome patients: A comparison of Patient Health Questionnaire-9 versus Hospital Anxiety and Depression Scale-Depression.
    Yuan J; Ding R; Wang L; Sheng L; Li J; Hu D
    J Psychosom Res; 2019 Jun; 121():24-28. PubMed ID: 30928210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the optimal cutoff values of HADS, PHQ-9 and GAD-7 as screening instruments for depression and anxiety in irritable bowel syndrome.
    Snijkers JTW; van den Oever W; Weerts ZZRM; Vork L; Mujagic Z; Leue C; Hesselink MAM; Kruimel JW; Muris JWM; Bogie RMM; Masclee AAM; Jonkers DMAE; Keszthelyi D
    Neurogastroenterol Motil; 2021 Dec; 33(12):e14161. PubMed ID: 33938601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for psychological distress in neurosurgical brain tumor patients using the Patient Health Questionnaire-2.
    Bunevicius A; Deltuva V; Tamasauskas S; Tamasauskas A; Bunevicius R
    Psychooncology; 2013 Aug; 22(8):1895-900. PubMed ID: 23233453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of depressive symptoms in type 2 diabetes using a two-stage survey design.
    Twist K; Stahl D; Amiel SA; Thomas S; Winkley K; Ismail K
    Psychosom Med; 2013 Oct; 75(8):791-7. PubMed ID: 23922402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the prevalence of depression among individuals with diabetes in a Medicaid managed-care program.
    Kahn LS; Fox CH; McIntyre RS; Tumiel-Berhalter L; Berdine DE; Lyle H
    Int J Psychiatry Med; 2008; 38(1):13-29. PubMed ID: 18624014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of depression and the accuracy of depression screening tools in migraine patients.
    Amoozegar F; Patten SB; Becker WJ; Bulloch AGM; Fiest KM; Davenport WJ; Carroll CR; Jette N
    Gen Hosp Psychiatry; 2017 Sep; 48():25-31. PubMed ID: 28917391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease.
    Stafford L; Berk M; Jackson HJ
    Gen Hosp Psychiatry; 2007; 29(5):417-24. PubMed ID: 17888808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Patient Health Questionnaire-9, Edinburgh Postnatal Depression Scale and Hospital Anxiety and Depression - Depression subscale scores by administration mode: An individual participant data differential item functioning meta-analysis.
    Harel D; Wu Y; Levis B; Fan S; Sun Y; Xu M; Rice DB; Boruff J; Markham S; Ioannidis JPA; Takwoingi Y; Patten SB; Ziegelstein RC; Cuijpers P; Gilbody S; Vigod S; Akena D; Benedetti A; Thombs BD;
    J Affect Disord; 2024 Sep; 361():674-683. PubMed ID: 38908554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidimensional Health Assessment Questionnaire as an Effective Tool to Screen for Depression in Routine Rheumatology Care.
    Morlà RM; Li T; Castrejon I; Luta G; Pincus T
    Arthritis Care Res (Hoboken); 2021 Jan; 73(1):120-129. PubMed ID: 32986905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study.
    Dowson C; Laing R; Barraclough R; Town I; Mulder R; Norris K; Drennan C
    N Z Med J; 2001 Oct; 114(1141):447-9. PubMed ID: 11700772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, symptom patterns and comorbidity of anxiety and depressive disorders in primary care in Qatar.
    Bener A; Ghuloum S; Abou-Saleh MT
    Soc Psychiatry Psychiatr Epidemiol; 2012 Mar; 47(3):439-46. PubMed ID: 21293844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.